Stéphane Boissel
Director/Board Member at ADOCIA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gérard Soula | M | 78 | 19 years | |
| Valérie Danaguezian | F | - | 18 years | |
| Olivier Soula | M | 53 | 19 years | |
| Laurent Arthaud | M | 61 |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 14 years |
| Irina Staatz-Granzer | M | 64 | 15 years | |
| Olivier Martinez | M | 54 | 14 years | |
| Prathyusha Durabaibu | F | 46 | 5 years | |
| Odile Belzunce | F | 44 | 19 years | |
| Philippe Chambon | M | 65 |
EG 427
 EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | - |
| Hedi Brahim | M | 43 |
Transgene, Inc.
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
| - |
| Claudia Mitchell | M | - | 3 years | |
| Gilles Brisson | M | 72 | 17 years | |
| Nathalie Trépo | F | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 2 years |
| Mads Dall | M | - | - | |
| James Meyers | M | 59 | 5 years | |
| John Markels | M | 58 | 4 years | |
| David Liens | M | 59 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | 7 years |
| Alberto Epstein | M | - |
EG 427
EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | - |
| Mizrahi Jacques | M | 70 | 10 years | |
| Gregory Davis | M | - | 4 years | |
| Philippe Archinard | M | 63 |
Transgene, Inc.
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
| - |
| Joseph Papa | M | 68 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 1 years |
| Ekaterina Smirnyagina | M | 58 | 11 years | |
| Katherine Bowdish | M | 67 | 3 years | |
| Valérie Ohannessian | F | 58 |
The French Society of Financial Analysts
| - |
| Gérard Lamy | M | - |
The French Society of Financial Analysts
| - |
| Géraldine Favre-Soula | F | - | - | |
| Amaury Dauge | M | 50 |
The French Society of Financial Analysts
| 20 years |
| Eric Quéméneur | M | 60 | 10 years | |
| Jean-Pierre Maureau | M | - |
The French Society of Financial Analysts
| - |
| Virginie Cayatte | F | 53 |
The French Society of Financial Analysts
| 10 years |
| Stéphane Legastelois | M | 64 |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | - |
| Emmanuel Pineau | M | - |
The French Society of Financial Analysts
| - |
| Sundar Kodiyalam | M | 62 |
EG 427
EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | 1 years |
| Christophe Auger | M | - |
The French Society of Financial Analysts
| - |
| Bertrand Buguet | M | 56 |
The French Society of Financial Analysts
| - |
| Benjamin Yerxa | M | 58 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Owen Smith | M | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Marie-Ange Verdickt | F | 60 |
The French Society of Financial Analysts
| - |
| Eric Girardin | M | 73 |
The French Society of Financial Analysts
| - |
| Sabine Dandiguian | F | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Jean-Luc Bélingard | M | 74 | 11 years | |
| Samuel Salot | M | - |
EG 427
EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | - |
| Paul Sieving | M | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Nathalie Dubois Stringfellow | M | - | 5 years | |
| Karen Wagner | M | 54 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Céline Scemama | F | 52 |
The French Society of Financial Analysts
| - |
| Henry Huyghues-Despointes | M | 71 |
The French Society of Financial Analysts
| - |
| Alexandre Lattès | M | 51 |
The French Society of Financial Analysts
| - |
| Paul Michalet | M | 61 |
The French Society of Financial Analysts
| - |
| Jérôme Bethbèze | M | 61 |
The French Society of Financial Analysts
| - |
| Magali Chessé | F | 49 |
The French Society of Financial Analysts
| - |
| Didier Laurens | M | 59 |
The French Society of Financial Analysts
| - |
| Jean-Baptiste Roussille | M | 53 |
The French Society of Financial Analysts
| - |
| Eric Marcel Xavier Pichet | M | - |
The French Society of Financial Analysts
| - |
| Guy-Philippe Bertin | M | - |
The French Society of Financial Analysts
| 33 years |
| Benoît Faure-Jarrosson | M | 60 |
The French Society of Financial Analysts
| - |
| Geoffroy de Ribains | M | - |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| Christophe Ricetti | M | 50 |
The French Society of Financial Analysts
| - |
| Yves Mordacq | M | 63 |
The French Society of Financial Analysts
| - |
| Vincent Bazi | M | 61 |
The French Society of Financial Analysts
| 32 years |
| Agnès Tixier | F | - |
The French Society of Financial Analysts
| - |
| Jeanne Cunicelli | F | 57 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | - |
| David Lamond | M | 49 |
EG 427
EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | 5 years |
| Michel Raud | M | 77 |
The French Society of Financial Analysts
| - |
| Béatrice Philippe | F | 76 |
The French Society of Financial Analysts
| 48 years |
| Christian Viguié | M | 66 |
The French Society of Financial Analysts
| - |
| Virginie Banet | F | 58 |
The French Society of Financial Analysts
| - |
| André Guilmard | M | - |
The French Society of Financial Analysts
| - |
| Daniel Karyotis | M | 63 |
The French Society of Financial Analysts
| - |
| Jean-Yves Bonnefoy | M | 64 |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | - |
| Mehdi Gasmi | M | 57 |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gary Loeb | M | 54 | 2 years | |
| Kathy Yi | F | 52 | 2 years | |
| William R. Loomis | M | 75 |
Lazard Group LLC
 Lazard Group LLC Investment ManagersFinance Lazard Group LLC provides financial advisory, asset management, and other financial services. The firm offers services related to mergers and acquisitions, strategic advisory, middle market advisory, capital markets and capital structure advisory, sovereign advisory, restructuring, and private fund advisory. The company was founded in 1840 and is headquartered in New York, NY. | 4 years |
| Heather Turner | F | 51 | 1 years | |
| Jason Fontenot | M | 54 | 5 years | |
| Mark McClung | M | 61 | 4 years | |
| CHRISTOPHE PETIT | M | - |
Université Paris Dauphine-PSL
| 1 years |
| Wendy Kool-Foulon | M | 50 |
Université Paris Dauphine-PSL
| 4 years |
| Laurence Zitvogel | M | 60 | - | |
| Nathalie Adda | M | 58 | 3 years | |
| Catherine Mathis | M | 58 | 24 years | |
| Liliane Bronstein | F | - |
Genclis SA
 Genclis SA Miscellaneous Commercial ServicesCommercial Services Genclis SA operates as a holding company with interest in providing research services to the medical and biotechnology firms. The company was founded by Jean Cinqualbre in 2006 and is headquartered in Vandoeuvre-les-Nancy, France. | 1 years |
| Laure-Hélène Mercier | F | 46 | 14 years | |
| Dominique Takizawa | F | 67 | 10 years | |
| Edward Rebar | M | 56 | 22 years | |
| Hemanshu Shah | M | 63 | 2 years | |
| Steven Mento | M | 72 | 14 years | |
| Bruce Jay Wasserstein | M | 76 |
Lazard Group LLC
Lazard Group LLC Investment ManagersFinance Lazard Group LLC provides financial advisory, asset management, and other financial services. The firm offers services related to mergers and acquisitions, strategic advisory, middle market advisory, capital markets and capital structure advisory, sovereign advisory, restructuring, and private fund advisory. The company was founded in 1840 and is headquartered in New York, NY. | 7 years |
| Sven Arne Andréasson | M | 72 |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | 14 years |
| Roger Jeffs | M | 62 | 2 years | |
| Marcel Rozencweig | M | 78 | 8 years | |
| Christian Lopez | M | - |
Université Paris Dauphine-PSL
| 3 years |
| Eric Vogelsinger | M | - |
Université Paris Dauphine-PSL
| 4 years |
| Frederic Benque | M | - |
Université Paris Dauphine-PSL
| 1 years |
| Clara Vu | F | - |
Université Paris Dauphine-PSL
| 4 years |
| Rémy Marcel | M | - |
Université Paris Dauphine-PSL
| 4 years |
| Oussama Faltas | M | - |
Université Paris Dauphine-PSL
| 1 years |
| Karine Arama | F | - |
Université Paris Dauphine-PSL
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 83 | 83.00% |
| United States | 17 | 17.00% |
| China | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stéphane Boissel
- Personal Network